Additional file 1 of Using four decades of FDA orphan drug designations to describe trends in rare disease drug development: substantial growth seen in development of drugs for rare oncologic, neurologic, and pediatric-onset diseases
收藏数据链接：
官方服务：
资源简介：
Additional file 1. Data Appendix.
创建时间：
2021-06-09
